Preparations > Ophthalmic Gel and Eye Drops > Brand-new Bai Nei-ting
Products
   · Preparations
      Cardiovascular
--Xin Weining (Tirofiban)
--Noradrenaline Bibartrate
--Li Shu Da (Simvastatin
Capsules)
--Xue Ke-an (Telmisartan
Hydrochlorothiazide Tablets)
--You Ke Ping (Indapamide
Tablets)
      Ophthalmic Gel and Eye Drops
--Brand-new Bai Nei-ting
--Bai Nei-ting
(Pirenoxine Sodium Eye Drops)
--Polyvinyl Alcohol Eye Drops
--Levofloxacin Hydrochloride
Eye Gel
--Bendazac Lysine Eye Drops
--Ganciclovir Eye Drops
--BingZhenQing Eye Drops
      Antibacterial
--Enoxacin
      Antibiotics
--Metronidazole
--Ping Li Da (Erythromycin
Enteric-coated Tablets)
      Antipyretics and Analgesic
--Analgin (Tablets)
--Li Mei Song (Nimesulide
Capsules)
· APIs
· Steroid Hormones APIs
· Healthcare Products
· Agricultural and Fine Chemicals
 
Trade Name: Brand-new Bai Nei-ting
English Name: Pirenoxine Eye Drops
“Brand-new Bai Nei-ting” is new product launched in July 2012 under the anti-cataract series of the Group, main treatment for early stage of age-related cataracts. The “Brand-new Bai Nei-ting” is the first suspension formulations of anti-cataract generic drugs in China. The suspension formulation could significantly increase the stability and safety of the drop.

Comparison between “Bai Nei-ting” and “Brand-new Bai Nei-ting” were as follows;
  Brand-new
Bai Nei-ting
Bai Nei-ting
Main Ingredient Pirenoxine Pirenoxine Sodium
Packing 5ml:0.25mg 15ml:0.8mg
Formulations Suspension Aqueous solution
Validity 18months 24months
Indications
  • Early stage of age-related cataract
  • Early stage of age-related cataract
  • Mild diabetics Cataract
  • Complicated Cataract
Comparisons
  • Solve the problems of instability of sodium in aqueous solution, greatly improve stability and safety to patients
  • Convenient to Use
  • Prevent the instability of sodium inside the aqueous pirenoxine and reduced the safety of the medicines
  • Relatively Inconvenient to Use

 

 
© 2018 China Grand Pharmaceutical and Healthcare Holdings Limited. All Rights Reserved. Disclaimer Powered by EQS TodayIR